Milk Fat Globule Membrane Antibodies and Lectins in Breast Cancer Prognosis
Author Information
Author(s): R.A. Walker
Primary Institution: University of Leicester
Hypothesis
Can milk fat globule membrane antibodies and lectins serve as independent prognostic markers in breast cancer?
Conclusion
The study concluded that none of the markers provided independent prognostic information beyond histological evaluation.
Supporting Evidence
- Only NCRC 11 staining showed a relationship to recurrent disease and overall survival.
- None of the lectins provided prognostic information.
- Histological grade was found to be a significant prognostic factor.
Takeaway
Researchers looked at certain proteins in breast cancer to see if they could predict how patients would do, but they found that these proteins didn't give any extra useful information beyond what doctors already know from looking at the tumor under a microscope.
Methodology
The study involved immunohistochemical assessment of 115 stage I and II breast carcinomas for various antibodies and lectins, followed by analysis of their relationship to recurrence and survival.
Potential Biases
Potential biases may arise from the subjective nature of histological grading and the variability in immunohistochemical methods.
Limitations
The study had a relatively small sample size and a shorter follow-up period compared to other studies.
Participant Demographics
Patients included were those with stage I and II breast carcinomas, with a median follow-up of 36 months.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website